Steven Carr, PhD

Steve is Senior Director of Proteomics at the Broad Institute of MIT and Harvard and an Institute Scientist. He is recognized as a leader in the development of novel proteomics methods and their application in biology and medicine. Prior to joining the Broad Institute in 2004, Steve held scientific leadership positions at GlaxoSmithKline and Millennium Pharmaceuticals (now Takeda). Steve and his group collaborate with scientists throughout the Broad community (comprised of MIT, Harvard University Faculty of Arts and Sciences, Harvard Medical School, and the Harvard-affiliated hospitals) and beyond to develop and apply state-of-the-art proteomics technology to address compelling questions in biology, chemistry, and clinical medicine. Steve has over 400 publications on the development and use of proteomics and biological mass spectrometry. He is Deputy Editor of the journal Molecular & Cellular Proteomics.

‍